Hair Loss Clinical Trials

A listing of Hair Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 87 clinical trials
Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

, Lichen Planopilaris Activity Index (LPPAI), and Frontal Fibrosing Alopecia Severity Score (FFASS).

  • 05 Jun, 2022
  • 1 location
Safety and Efficacy of Fecal Microbiota Transplantation

The gut microbiota is critical to health and functions with a level of complexity comparable to that of an organ system. Dysbiosis, or alterations of this gut microbiota ecology, have been implicated in a number of disease states. Fecal microbiota transplantation (FMT), defined as infusion of feces from healthy donors …

crohn's disease
graft-versus-host disease
disease or disorder
  • 23 Mar, 2022
  • 1 location
Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?

substantial. Anti-cancer treatment can have a number of side effects including nausea, fatigue, vomiting, anorexia and alopecia. Late effects such as cancer related fatigue (CRF) are very persistent. CRF is a

  • 23 Mar, 2022
  • 1 location
Treatment and Natural History Study of Lymphomatoid Granulomatosis

interferon. Alpha interferon can have flu-like side effects of headache, fever, chills, and body aches. EPOCH-R drugs can cause gastrointestinal problems, hair loss, and weakness. G-CSF can cause bone pain

colony stimulating factor
hair loss
  • 29 Jul, 2022
  • 1 location
Onabotulinum Toxin A in Direct Brow Lift

from supraorbital nerve damage. Other complications include alopecia and brow asymmetry. However, one of the main critiques of direct brow lift remains the poor cosmesis that can result from scarring

  • 03 Feb, 2021
  • 1 location
A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections

The purpose of this study is to evaluate changes in vascular parameters and the prevalence of side effects in subjects receiving 1 cc (200mg) every 2 weeks intramuscular (IM) of Testosterone Cypionate versus subjects receiving 11mg three times daily (TID) Natesto to participant with clinical hypogonadism.

testosterone cypionate 200 mg/ml
hypogonadotropic hypogonadism
12-lead electrocardiogram
  • 19 Jun, 2022
  • 1 location
Efficacy and Safety of Topical Nicotinamide in Treatment of Discoid Lupus Erythematosus

Cutaneous lupus erythematosus (CLE) is lupus affecting the skin. In this autoimmune disease, the body's immune system attacks healthy skin. There are 3 main types: Acute cutaneous lupus, Subacute cutaneous lupus, and Chronic cutaneous lupus ("discoid lupus"). Lupus most often appears between the ages of 20 and 50 years; it …

Accepts healthy volunteers
  • 12 May, 2022
  • 1 location
Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma

This phase II trial studies how well intensity-modulated stereotactic radiation therapy works in treating patients with grade II-IV glioma. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue.

karnofsky performance status
  • 31 Jan, 2022
  • 1 location
Ultrasound in Diagnosing Patients With Skin Lesions

This trial studies the use of a novel non-invasive ultrasound technique in diagnosing patents with skin lesions. Diagnostic procedures, such as ultrasound, may be a less invasive way to check skin lesions for skin cancer and other skin disorders.

  • 05 Jun, 2022
  • 1 location
Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID)

The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry ("Long-COVID" "Long-haulers"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, …

  • 06 Aug, 2021
  • 1 location